Skip to main content
Menu

Vanadis Core Reagent Cartridge II

Vanadis Core™ qualitative assay for screening the risk of trisomy 21, 18, 13 and sex chromosome aneuploidies in fetal cell-free DNA from pregnant women ≥10 weeks gestation. Uses rolling circle amplification technology for automated processing of up to 84 samples with high detection rates and low false positives.

Feature Specification
Application Noninvasive Prenatal Testing (NIPT)

Vanadis Core™ qualitative assay for screening the risk of trisomy 21, 18, 13 and sex chromosome aneuploidies in fetal cell-free DNA from pregnant women ≥10 weeks gestation. Uses rolling circle amplification technology for automated processing of up to 84 samples with high detection rates and low false positives.

Product variant
Unit Size: 84 samples
Part #:
3222-002B
For in vitro diagnostic use. This product is only available where licensed in accordance with law. Please contact your local representative for availability.
Request more information

Overview

Qualitative IVD assay for screening trisomy 21, 18, 13 and sex chromosome aneuploidies in fetal cell-free DNA from pregnant women ≥10 weeks gestation. Uses rolling circle amplification with fluorescent probes for 84 samples. Compatible with Vanadis Core system. Aids prenatal screening as part of comprehensive clinical assessment. Features automated processing with high detection rates and low false positives.

Specifications

Application
Noninvasive Prenatal Testing (NIPT)
Brand
Vanadis Core™
Disorders
Common Aneuploidies
Sex Chromosome Aneuploidies
Instrument Compatibility
Vanadis NIPT System
Regulatory Status
CE-IVD marked (Notified Body 0537)
Sample Type
Serum
Storage Conditions
Store at 2-8°C (refrigerated), Do not freeze. Protect from light.
Technology
Rolling Circle Amplification (RCA)
Unit Size
84 samples

Resources

Are you looking for resources, click on the resource type to explore further.

Scroll Icon

Revvity AI Assistant Beta